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Evidence for a Pioneer Round of mRNA Translation:
mRNAs Subject to Nonsense-Mediated Decay
in Mammalian Cells Are Bound by CBP80 and CBP20
Tethering any of the three Upf proteins to the 3-untrans-
lated region of -globin mRNA converts the normal ter-
mination codon to the type that elicits NMD (Lykke-
Andersen et al., 2000). (2) Upf3 protein is predominantly
localized to nuclei, while Upf1 and Upf2 proteins are
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detected only in the cytoplasm, suggesting that Upf3601 Elmwood Avenue, Box 712
protein associates with spliced mRNA before Upf1 andRochester, New York 14642
Upf2 proteins (Lykke-Andersen et al., 2000; Serin et al.,
2001). (3) Upf3 protein can be detected as a component
of spliced mRNP in HeLa cells (Lykke-Andersen et al.,Summary
2000; notably, Upf1 and Upf2 proteins were not as-
sayed). (4) Upf3 protein can not be detected as a compo-Nonsense-mediated decay (NMD) eliminates mRNAs
nent of the splicing-dependent complex formed in HeLathat prematurely terminate translation. We used anti-
cell nuclear extract (data not shown), suggesting that itbody to the nuclear cap binding protein CBP80 or its
may be recruited to mRNP after complex formation.cytoplasmic counterpart eIF4E to immunopurify RNP
Most mammalian mRNAs are subject to NMD beforecontaining nonsense-free or nonsense-containing
they are released from an association with nuclei intotranscripts. Data indicate that NMD takes place in as-
the cytoplasm (see, e.g., Belgrader et al., 1993; Cartersociation with CBP80. We defined other components
et al., 1996; Zhang et al., 1998a, 1998b; Thermann et al.,of NMD-susceptible mRNP as CBP20, PABP2, eIF4G,
1998). However, some mRNAs are degraded after theyand the NMD factors Upf2 and Upf3. Consistent with
are released into the cytoplasm (see, e.g., Sun et al.,the dependence of NMD on translation, the NMD of
2000; Rajavel and Neufeld, 2001). NMD depends onCBP80-bound mRNA is blocked by cycloheximide or
translation regardless of its cellular site, which is readilysuppressor tRNA. These findings provide evidence
conceivable for cytoplasmic NMD but less so for nu-that translation can take place in association with
cleus-associated NMD. As one possibility, nucleus-CBP80. They also indicate that CBP80-bound mRNA
associated NMD takes place during mRNA export at aundergoes a “pioneer” round of translation, before
point when mRNA copurifies with nuclei but is translatedCBP80-CBP20 are replaced by eIF4E, and Upf2 and
by cytoplasmic ribosomes. A precedent for this possibil-Upf3 proteins dissociate from upstream of exon-exon
ity is provided by the Balbiani ring granule of the insectjunctions.
Chironomus tentans. This granule, a 35–40 kb mRNP,
is invariably exported from nuclei to the cytoplasm
Introduction 5-end first so that cytoplasmic ribosomes associate
with the 5 end before the 3 end has transited the nu-
Mammalian cells have evolved numerous ways to en- clear pore complex (Mehlin et al., 1992). Nevertheless,
sure the quality of mRNA and, by so doing, the accuracy the possibility that nucleus-associated NMD reflects a
of gene expression (reviewed in Maquat and Carmi- translation-like mechanism in the nucleoplasm can not
chael, 2001). One such way surveys all translated be ruled out.
mRNAs in order to distinguish those that prematurely Much can be learned about the mechanism of NMD
terminate translation from those that do not. If transla- at either cellular site by continuing to identify proteins
tion termination is sufficiently premature, then the mRNA associated with the process. One way to do so is to
will be subject to nonsense-mediated decay (NMD) (re- identify mRNP proteins. We were particularly interested
viewed in Maquat, 1995, 2000; Li and Wilkinson, 1998; in determining if there is a difference in the cap binding
Hentze and Kulozik, 1999; Frischmeyer and Dietz, 1999). protein associated with mRNA that is a substrate for
Generally, NMD is elicited if translation terminates more nucleus-associated NMD and mRNA that is a substrate
than 50–55 nucleotides upstream of the 3-most exon- for cytoplasmic NMD. CBP80 is a component of the
exon junction of an mRNA, and most probably requires nuclear cap binding complex that is added cotranscrip-
the splicing-dependent deposition of proteins known to tionally and functions in nuclear RNA processes such
occur 20–24 nucleotides upstream of exon-exon junc- as pre-mRNA splicing (Izaurralde et al., 1994; Lewis and
tions (Le Hir et al., 2000a, 2000b). According to one Izaurralde, 1997). Mammalian CBP80 is likely to be a
scenario, one or more of these proteins recruits Upf3 nucleocytoplasmic shuttling protein based on studies
protein, a nucleocytoplasmic shuttling protein involved of its ortholog in C. tentans (Visa et al., 1996) or S.
in NMD (Lykke-Andersen et al., 2000; Serin et al., 2001). cerevisiae (Shen et al., 2000). eIF4E is the 24 kDa cyto-
plasmic cap binding protein that replaces CBP80 at anUpf3 protein then interacts directly with Upf2 protein,
undefined point after mRNA export to the cytoplasm andwhich in turn interacts with Upf1 protein (Serin et al.,
functions in translation initiation (reviewed in Gingras et2001). Several observations support this scenario. (1)
al., 1999). The finding that a fraction of eIF4E localizes
to the nucleus suggests that eIF4E may also manifest1Correspondence: lynne_maquat@urmc.rochester.edu
a nuclear function (Lejbkowicz et al., 1992; Dostie et2 Present address: Division of Radiation Biology, Faculty of Pharma-
al., 2000). Recent studies of S. cerevisiae suggest thatceutical Science, Kanazawa University, Takana-machi 13-1, Kana-
zawa 920-0934 Japan. CBP80, together with the translation initiation factor
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eIF4G, mediates translation initiation. First, CBP80 was mRNP proteins in immunopurified complexes does not
depend on the presence of these RNAs since they repre-found to bind eIF4G in vitro (Fortes et al., 2000). Second,
sent only a small fraction of cellular RNA. However, quanti-TAP-tagged CBP20, which forms the heteromeric nu-
tative analysis of these RNAs in the complexes allows forclear cap binding complex with CBP80, was found to
identification of those proteins associated with NMD.associate with eIF4G in extracts (Fortes et al., 2000).
Cos cells were transiently transfected with two plasmids:Furthermore, CBP80 added to extracts was found to
a test pmCMV-Gl plasmid, which expressed -globinstimulate translation 2.5-fold, provided that extracts
(Gl) mRNA that was either nonsense-free (Norm) or har-were derived from strains harboring a mutated form of
bored a premature termination codon at position 39eIF4G that interacted only weakly with eIF4E and the
within exon 2 (Ter) (Zhang et al., 1998a; Figure 1A), andpoly(A) binding protein Pab1p (Fortes et al., 2000). Very
the reference phCMV-MUP plasmid (Belgrader and Ma-recently, CBP80 was also shown to interact with eIF4G in
quat, 1994), which expressed mRNA for the mouse majormammalian cells (McKendrick et al., 2001). Considering
urinary protein (MUP) and served to control for variationsthat nucleus-associated NMD is restricted to newly syn-
in the efficiencies of cell transfection and RNA recovery.thesized mRNA, CBP80 could be involved. In contrast,
After 40 hr, cells were lysed. Lysates were first clearedeIF4E was the logical cap binding protein to be involved
by incubation with protein A-agarose beads and subse-in cytoplasmic NMD.
quently incubated with either anti-CBP80 antibody or,Here, we use Western blotting and RT-PCR to analyze,
as a control, normal rabbit serum (NRS). After 90 min atrespectively, the protein and RNA components of mam-
4C, tRNA, RNase inhibitor and protein A-agarose beadsmalian cell RNP immunopurified using antibody to either
were added, and the incubation was continued for an-CBP80 or eIF4E. Remarkably, our results indicate that
other 60 min. The beads were washed extensively,both nucleus-associated and cytoplasmic NMD take
bound material was eluted with SDS-containing buffer,place in association with CBP80. Therefore, a first round
and protein and RNA were purified for analysis by West-of translation in mammalian cells can take place in asso-
ern blotting and RT-PCR, respectively.ciation with CBP80. We identify other proteins associ-
The results of Western blotting revealed that CBP80ated with CBP80-bound mRNA as CBP20, poly(A) bind-
was immunopurified using anti-CBP80 antibody but noting protein II (PABP2), and Upf3 protein, which are
NRS (Figure 1B, left), indicating that immunopurificationprimarily nuclear, and eIF4G, Upf2 protein, and ribo-
was specific for CBP80-containing complexes. The re-somal protein L10, which are primarily cytoplasmic.
sults of RT-PCR revealed that Gl and MUP mRNAs wereCBP20 forms the nuclear cap binding complex with
also immunopurified using anti-CBP80 antibody but notCBP80 (Izaurralde et al., 1994), PABP2 binds nascent
NRS (Figure 1B, right), offering additional evidence forpoly(A) tails to stimulate their extension and control their
the specificity of immunopurification. Quantitation oflength (Wahle, 1991; Bienroth et al., 1993), eIF4G medi-
each CBP80-associated mRNA demonstrated that theates translation initiation in association with eIF4E (re-
level of nonsense-containing (Ter) Gl mRNA was re-viewed in Gingras et al., 1999) and, presumably, CBP80
duced to 19%  4% the level of nonsense-free (Norm)(Fortes et al., 2000; McKendrick et al., 2001), and Upf2
Gl mRNA (Figure 1B, right). This level of reduction repre-and Upf3 proteins function in NMD (Lykke-Andersen et
sented the full extent of NMD, since the level of non-al., 2000; Mendell et al., 2000; Serin et al., 2001). The
sense-containing Gl mRNA in total-cell mRNA (i.e.,presence of ribosomal protein, together with our finding
mRNA that had not been immunopurified) was reducedthat the NMD of mRNA immunopurified using antibody
to essentially the same extent (i.e., 23%  4% of non-to CBP80 is abrogated by cycloheximide or suppressor
sense-free Gl mRNA) (Figure 1B, right). These data sug-tRNA, is consistent with the well-established depen-
gest that the NMD of Gl mRNA takes place in associationdence of NMD on translation (reviewed in Maquat, 2000).
with CBP80.We suggest the possibility of a “pioneer” round of trans-
In order to gain additional insight into the nature of
lation involving CBP80 that, depending on the mRNA,
mRNP that is a target for NMD, the experiment was
takes place either in association with nuclei or in the
scaled up and repeated using anti-CBP80 antibody and,
cytoplasm. in parallel, anti-eIF4E antibody. Results of Western blot-
ting confirmed the specificity of each immunopurifica-
Results tion by demonstrating that CBP80 but not eIF4E was
immunopurified using anti-CBP80 antibody, eIF4E but
Nucleus-Associated NMD of -Globin mRNA Takes not CBP80 was immunopurified using anti-eIF4E anti-
Place In Association with CBP80, CBP20, eIF4G, body, and neither protein was immunopurified using NRS
PABP2, and Upf2 and Upf3 Proteins (Figure 1C, upper). Calculations indicated that 34% 
Considering that -globin mRNA is subject to nucleus- 2% of cellular CBP80 was immunopurified using anti-
associated NMD in nonerythroid cells such as HeLa and CBP80 antibody, and 15%  1% of cellular eIF4E was
Cos cells (Kugler et al., 1995; Zhang et al., 1998a), we immunopurified using anti-eIF4E antibody. The finding
first aimed to determine if NMD is evident for -globin that the NMD of Gl mRNA takes place in association
mRNP immunopurified using anti-CBP80 antibody. We with CBP80 was corroborated using RT-PCR: the level
assayed endogenous CBP80 in order to avoid artifac- of nonsense-containing Gl mRNA was 17%  4% and
tual interactions that could be due to abnormally high 20%  4% of normal in complexes immunopurified us-
levels of CBP80 produced from transiently introduced ex- ing anti-CBP80 antibody and in total-cell RNA, respec-
pression vectors. Therefore, only RNA substrates—either tively (Figure 1C, lower). The level of nonsense-con-
nonsense-free or nonsense-containing—derived from taining Gl mRNA was comparably reduced to 12% 
3% of normal in complexes immunopurified using anti-transiently introduced vectors. Notably, the detection of
Figure 1. Nonsense-Containing -Globin (Gl) mRNP Immunopurified Using Anti-CBP80 Antibody Is a Target for NMD
(A) Structure of the pmCMV-Gl test plasmids, which harbored either a nonsense free (Norm) Gl allele or a TAG nonsense codon at position
39 (Ter). Cos cells were transiently transfected with a test pmCMV-Gl plasmid and the reference plasmid phCMV-MUP.
(B, left) Total-cell RNP was then immunopurified using either normal rabbit serum (NRS) or anti-CBP80 antibody (-CBP80) and subjected to
Western blotting using anti-CBP80 antibody. The three leftmost lanes analyzed decreasing amounts of protein, demonstrating that the
conditions used for Western blotting were quantitative.
(B, right) RNA was purified from total-cell RNP either before (-) immunopurification (IP) or after immunopurification (NRS or -CBP80). The
levels of Gl and MUP mRNAs were then analyzed by RT-PCR. The leftmost lane demonstrates the absence of either mRNA in untransfected
cells, and the adjacent eight lanes analyzed decreasing amounts of RNA, demonstrating that the conditions of RT-PCR were quantitative.
(C, upper) As in B (left) except that immunopurifications were scaled up (each IP lane derives from either 8  105 or 32  105 cells) and also
performed with anti-eIF4E antibody, and Western blotting also utilized anti-eIF4E, anti-CBP20, anti-eIF4G, anti-PABP2, anti-human Upf1, anti-
human Upf2, anti-human Upf3/3X, and antiribosomal protein (rp) L10 antibodies. Furthermore, the percent (%) of each protein in each IP
(tabulated to the right) was determined by comparing the Western blot intensity of each IP lane to the intensities of 3-fold dilutions of extract
from either 8  105 or 32  105 cells before IP (three leftmost lanes). For easy visualization, bands corresponding to antibody (e.g., see Ab
in B, left) are not shown. Protein detectably reacting with anti-Upf3/3X antibody is likely to be Upf3 protein rather than Upf3X protein (which
derives from the X-linked UPF3 gene that is related to the UPF3 gene) since it comigrated with the HeLa cell Upf3 protein. The Upf3X isoform
likely comigrated with antibody, making it undetectable using electrophoresis in either one or two dimensions (data not shown).
(C, lower) As in B (right) except that RNA analysis was extended to immunopurifications using anti-eIF4E antibody. Each panel of results is




eIF4E antibody (Figure 1C, lower). These results demon-
strate that more than 80% of CBP80-bound Gl mRNA is
degraded when the mRNA harbors the nonsense codon.
Since CBP80 is thought to be replaced by eIF4E in the
cytoplasm (Visa et al., 1996; Shen et al., 2000), it is likely
that only the 17% of nonsense-containing Gl mRNA that
escapes NMD is available for binding to eIF4E. Consider-
ing that the difference between 17% and 12% is within
experimental variations, the finding that 12% of non-
sense-containing Gl mRNA is bound by eIF4E may indi-
cate that eIF4E-bound Gl mRNA is essentially immune
to NMD. Alternatively, the difference may indicate that
NMD also involves eIF4E-bound mRNA.
Additional evidence for specificity of the immunopuri-
fications and the idea that CBP80-bound mRNA is sus-
ceptible to NMD was provided by the findings that com-
plexes immunopurified using anti-CBP80 antibody but
not anti-eIF4E antibody contained four other proteins
detectable by Western blotting: CBP20, which together
with CBP80 forms the heterodimeric nuclear cap binding
complex; poly(A) binding protein II (PABP2), which binds
newly synthesized poly(A) tails of pre-mRNA and mRNA;
and Upf2 and Upf3 proteins (Figure 1C, upper). Since
Upf2 and Upf3 proteins are known to be involved in NMD,
their presence in CBP80-containing but not eIF4E-con-
taining complexes offers strong evidence that Gl mRNA
is a substrate for NMD when bound by CBP80 and is
not detectably a substrate when bound by eIF4E. The
presence of Upf2 and Upf3 proteins as well as PABP2
in CBP80-containing complexes was dependent on RNA
as evidenced by their absence in immunopurified com-
Figure 2. The NMD of CBP80-Bound Gl mRNA Is Nucleus-Associatedplexes that were treated with RNase A prior to dissocia-
As in Figure 1B except that nuclear and cytoplasmic fractions weretion from anti-CBP80 antibody (data not shown). In con-
immunopurified with NRS and anti-CBP80 antibody. Nuclear frac-trast, the presence of CBP20 in CBP80-containing
tions were free of cytoplasm as evidenced by the absence of detect-complexes was not dependent on RNA (data not shown),
able reactivity with anti-eIF4A antibody (data not shown). The
as would be expected considering the direct interaction amount of reactivity obtained with anti-CBP80 antibody after immu-
between CBP20 and CBP80. Interestingly, CBP20, nopurification of nuclear and cytoplasmic fractions can be quantita-
PABP2, and Upf3 protein are mostly nuclear, consistent tively compared, as evidenced by analyzing decreasing amounts of
protein, demonstrating that the conditions used for Western blottingwith the newly synthesized nature of both CBP80-con-
were quantitative (data not shown). The efficiency of NMD variedtaining mRNP and nucleus-associated NMD. However,
by no more than 2% in two independently performed transfections.PABP2 and Upf3 proteins shuttle, opening up the possi-
bility that nucleus-associated NMD could take place on
the cytoplasmic side of the nuclear envelope. In support
not shown), which has been shown to be undetectable inof this possibility, Upf2p is not detected in nuclei (Lykke-
nuclei (Lejbkowicz et al., 1992). CBP80-bound Gl mRNAAndersen et al., 2000; Serin et al., 2001). Upf1 protein,
was detected by RT-PCR in both nuclear and cyto-which is known to interact with Upf2 and Upf3 proteins
plasmic fractions (Figure 2), consistent with CBP80 be-in HeLa cells, was not detected in either CBP80-bound
ing a shuttling protein. Furthermore, the extent of NMDor eIF4E-bound Gl mRNA (Figure 1C, upper). Its absence
for CBP80-bound Gl mRNA in both cellular fractionsfrom CBP80-bound mRNA is consistent with its putative
was comparable (Figure 2). This result is expected givenrole in NMD only after translation termination (see Dis-
that Gl mRNA is subject to nucleus-associated NMDcussion). Both CBP80 and eIF4E were associated with
(Zhang et al., 1998a; Thermann et al., 1998), and is con-eIF4G and ribosomal protein L10 (Figure 1C, upper),
sistent with the idea that NMD takes place in associationconsistent with the translational dependence of NMD
with CBP80.(reviewed in Maquat, 2000). Notably, the amounts of
As another means of confirming that the CBP80-eIF4G and L10 associated with CBP80 were small but
containing complex is a substrate for NMD, mRNP wasreasonable considering the amounts associated with
immunopurified from untransfected cells using anti-eIF4E, which supports the bulk of cellular translation.
Upf3/3X antibody. This antibody reacts with Upf3 andIn search of additional indications that the CBP80-
Upf3X proteins, which derive from non-X-linked andbound Gl mRNP complexes under evaluation realisti-
X-linked UPF3 genes, respectively (Lykke-Andersen etcally represent complexes formed in vivo, mRNP immu-
al., 2000; Serin et al., 2001; data not shown). Notably,nopurified using anti-CBP80 antibody was isolated from
both Upf3 and Upf3X proteins are mostly nuclear andnuclear and cytoplasmic fractions of transfected cells.
shuttle between nuclei and cytoplasm (Lykke-AndersenNuclear fractions were not contaminated by cytoplasm,
as indicated by the absence of detectable eIF4A (data et al., 2000; Serin et al., 2001). Consistent with findings
NMD Takes Place on CBP80-Bound mRNA
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Cytoplasmic NMD of GPx1 mRNA Also Takes Place
In Association with CBP80, CBP20, eIF4G, PABP2,
and Upf2 and Upf3 Proteins
Unlike nucleus-associated NMD, for which data are
lacking, cytoplasmic NMD has been demonstrated to
take place on cytoplasmic ribosomes (Rajavel and Neu-
feld, 2001). In order to gain insight into the mechanistic
relationship between NMD at the two cellular sites, the
cap binding protein associated with mRNA that is a
substrate for cytoplasmic NMD was determined. To this
end, Cos cells were transiently transfected with two
plasmids: a test pmCMV-GPx1 plasmid, which ex-
pressed glutathione peroxidase1 (GPx1) mRNA that was
either nonsense-free (Norm) or harbored a prematureFigure 3. RNP Immunopurified Using Anti-Upf3/3X Antibody Con-
termination codon at position 46 within exon 1 (Ter)tains CBP80, PABP2, and Upf2 Protein But Not eIF4E or Upf1 Protein
(Moriarty et al., 1998; Figure 5A), and the referenceAs in Figure 1C, upper, except that cells were not transfected and
phCMV-MUP plasmid. Immunopurifications were per-immunopurifications were performed with anti-Upf3/3X antibody.
Results are representative of three independently performed immu- formed using either anti-CBP80 or anti-eIF4E antibody
nopurifications. as described above for studies of Gl mRNP.
The results of Western blotting confirmed the specific-
ity of each immunopurification, i.e., the absence of de-described above, CBP80, PABP2, and Upf2 protein, but
tectable eIF4E in the immunopurification using anti-not eIF4E or Upf1 protein, were detected in complexes
CBP80 antibody, the absence of detectable CBP80 inimmunopurified using anti-Upf3/3X antibody (Figure 3).
the immunopurification using anti-eIF4E antibody, andThe presence of CBP80 and the absence of eIF4E in
the absence of either protein in the immunopurificationcomplexes immunopurified using anti-Upf3/3X antibody
using NRS (Figure 5B, upper). Furthermore, quantitationcorroborate the idea that NMD is largely confined to
of GPx1 and MUP mRNAs by RT-PCR revealed the pres-CBP80-bound mRNA. The finding that there is more
ence of each mRNA in immunopurifications using anti-Upf2 protein in complexes immunopurified using anti-
CBP80 or anti-eIF4E antibody but not NRS (Figure 5B,Upf3/3X antibody than in complexes immunopurified
lower). Remarkably, despite its cytoplasmic location,using anti-CBP80 antibody is consistent with data dem-
NMD was evident for CBP80-bound GPx1 mRNA: theonstrating that Upf2 and Upf3 proteins can interact inde-
level of nonsense-containing mRNA was 25%  5% ofpendently of RNA (Lykke-Andersen et al., 2000),
normal, which was comparable to the (29%  4% ofwhereas the interaction between CBP80 and Upf3 is
normal) level of nonsense-containing mRNA that haddependent on RNA (data not shown).
not undergone immunopurification (Figure 5B, lower).
The level of nonsense-containing mRNA bound by eIF4E
Evidence that CBP80-Bound Gl mRNA
was 21%  2% of normal (Figure 5B, lower), indicating
Is Translated that GPx1 mRNA is no longer appreciably susceptible
The finding that NMD takes place in association with to NMD once CBP80 is replaced by eIF4E, as was found
CBP80 implies that CBP80-bound mRNA can be trans- for Gl mRNA. The difference between 25% and 21%
lated, which is consistent with the presence of eIF4G may indicate that NMD involves eIF4E-bound mRNA.
and ribosomal protein in immunopurifications using anti- Nevertheless, as was concluded from the studies of Gl
CBP80 antibody (Figure 1C). To obtain more direct evi- mRNA, NMD involves CBP80-bound mRNA.
dence for the translatability of CBP80-bound mRNA, the Also consistent with findings using Gl mRNA, results
effect of a block in translation on the level of total-cell of Western blotting revealed that CBP80-bound GPx1
CBP80-bound mRNA was quantitated. Addition of 100 g/ mRNA, but not eIF4E-bound GPx1 mRNA, was associ-
ml of cycloheximide for two hr prior to cell harvesting ated with CBP20, PABP2, Upf2 protein, and Upf3 protein
abrogated the NMD of CBP80-bound Gl mRNA so that (Figure 5B, upper). Furthermore, both CBP80-bound and
the level of nonsense-containing mRNA was increased eIF4E-bound GPx1 mRNAs were associated with eIF4G
from 15% to 42% of normal (Figure 4A). Therefore, and ribosomal protein L10, and neither was detectably
CBP80-bound mRNA is a substrate for protein synthe- associated with Upf1 protein (Figure 5B, upper; data not
sis. This conclusion was corroborated using an amber shown for L10). The analysis of cell fractions was used
suppressor tRNA (Belgrader et al., 1993) that directs to corroborate the biological significance of the GPx1
the incorporation of serine at the nonsense codon of mRNP under study. NMD was evident for CBP80-bound
nonsense-containing Gl mRNA. Coexpression of a plas- GPx1 mRNA in the cytoplasmic but not nuclear fraction
mid producing suppressor tRNA abrogated the NMD (Figure 6). This result is consistent with the fact that
of CBP80-bound Gl mRNA: the level of nonsense- NMD of GPx1 mRNA takes place only after export to
containing Gl mRNA was increased from 23% of normal the cytoplasm, and indicates that translation in the cyto-
to 37%, 46%, or 62% of normal as the ratio of suppressor plasm can take place in association with CBP80.
tRNA expression vector to Gl mRNA expression vector
was increased (Figure 4B). In contrast, coexpression Discussion
of a plasmid harboring the suppressor tRNA gene in
antisense orientation had no effect on the NMD of We have determined that mRNA bound by the cap bind-
ing proteins CBP80 and CBP20 and the poly(A) bindingCBP80-bound Gl mRNA (Figure 4B).
Cell
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Figure 4. Cycloheximide and Suppressor tRNA Abrogate the NMD of CBP80-Bound Gl mRNA, Providing Evidence that CBP80-Bound mRNA
Is Translated
(A) As in Figure 1B except that cycloheximide was (CHX) or was not (	CHX) added two hr prior to cell harvest.
(B) As in Figure 1B except that a derivative of p53tsSu that harbored the amber suppressor tRNA in either antisense orientation (	Su) or
sense orientation at increasing concentrations (1X, 2X, and 4X Su) was included in the transfection, and immunopurifications using NRS were
not performed. Results are representative of two independently performed experiments.
protein PABP2 is translated and subject to NMD regard- cleus-associated NMD. Upf1 and Upf2 proteins could
also be present in nuclei at undetectable levels. Evenless of whether NMD takes place in association with
nuclei or in the cytoplasm. Even though CBP80, CBP20, our finding that the nucleus-associated NMD of CBP80-
bound Gl mRNA is abrogated by either a cycloheximide-and PABP2 are primarily nuclear, their function in cyto-
plasmic NMD is attributable to their ability to shuttle induced block in translation or suppressor tRNA that
recognizes the nonsense codon as a codon for serinebetween nuclei and cytoplasm. The site of nucleus-
associated NMD remains uncertain. For the sake of unifi- does not preclude the possibility of cycloheximide-sen-
sitive or suppressor tRNA-responsive translation in nu-cation, it could be argued that nucleus-associated NMD
also takes place in the cytoplasm, albeit during the pro- clei. Nevertheless, the simplest interpretation of existing
data is that nucleus-associated NMD involves cyto-cess of mRNA export from nuclei. Consistent with this
possibility, but certainly not proof, the replacement of plasmic ribosomes during mRNA export.
Our findings are important for a number of reasons.CBP80 and CBP20 by the primarily cytoplasmic cap
binding protein eIF4E is generally concomitant with the Most notably, CBP80, CBP20, and, presumably, PABP2,
can now be defined as components of the translationloss of susceptibility to NMD for both nucleus-associ-
ated and cytoplasmic NMD. Furthermore, Upf2 protein, initiation complex that typifies early rounds—possibly
exclusively the first round—of translation in mammalianwhich is also bound to mRNA subject to NMD at either
cellular site, is detected only in the cytoplasm, albeit cells. The idea of a “pioneer” round that is distinct from
subsequent rounds has recently been suggested formostly at the nuclear periphery (Lykke-Andersen et al.,
2000; Serin et al., 2001). Additionally, Upf1 protein, which transcription by RNA polymerase II (reviewed in Or-
phanides and Reinberg, 2000). A pioneer round of trans-is known to be required for NMD (Sun et al., 1998) and
interacts with Upf2 protein (Serin et al., 2001), is also lation during which NMD generally functions certainly
makes sense considering that NMD surveys mRNAs todetected only in the cytoplasm (Lykke-Andersen et al.,
2000; Serin et al., 2001). However, the fact that some eliminate those that prematurely terminate translation
as a form of quality control. Notably, our data do noteIF4E is present in nuclei makes the replacement of
CBP80-CBP20 with eIF4E in nuclei a possibility for nu- eliminate the possibility that NMD takes place on eIF4E-
NMD Takes Place on CBP80-Bound mRNA
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Figure 5. Nonsense-Containing Glutathione
Peroxidase 1 (GPx1) mRNA Immunopurified Us-
ing Anti-CBP80 Antibody Is Subject to NMD
(A) Structure of the pmCMV-GPx1 test plas-
mids, which harbored either a nonsense-free
(Norm) GPx1 allele or a TAA nonsense codon
at position 46 (Ter).
(B) As in Figure 1C except that GPx1 mRNA
was analyzed in place of Gl mRNA. Each
panel of results is representative of three in-
dependently performed experiments, and the
efficiency of NMD varied by no more than 5%
(see text for specific standard deviations).
bound mRNA. The finding that the absence of CBP80 demonstrating that CBP80 and eIF4G coimmunoprecipi-
tate (McKendrick et al., 2001), recent studies of S. cere-in S. cerevisiae does not preclude NMD (Das et al., 2000)
indicates that eIF4E-bound mRNA can serve as a sub- visiae demonstrated that eIF4G1 interacts directly with
CBP80 in vitro in a way that is competed by eIF4E (Fortesstrate for NMD when CBP80 is absent. Only when more
is understood about the rate of and requirements for et al., 2000). Additionally, TAP-tagged CBP20 copurified
with CBP80, eIF4G1, and a small amount of eIF4E, indi-CBP80-CBP20 replacement by eIF4E will there be an
understanding of whether or not a fraction of eIF4E- cating an association in extracts. For reasons unknown,
however, CBP80-CBP20 stimulated cap-dependent trans-bound mRNA, in addition to CBP80-bound mRNA, nor-
mally serves as a substrate for NMD. lation only in extracts of yeast strains expressing eIF4G1
that harbored mutations weakening its binding to eIF4EDetails of the intermolecular interactions within the
pioneer initiation complex, and in particular, if they relate and Pab1p; in fact, addition of CBP80–CBP20 to wild-
type extracts inhibited translation (Fortes et al., 2000).to or are different from those of the steady-state initia-
tion complex, have yet to be resolved. In the steady- The CBP80-interacting region of S. cerevisiae eIF4G1
was found to reside between residues 490 and 592 (For-state initiation complex, eIF4G is a multipurpose adap-
tor, interacting directly with eIF4E, eIF3, eIF4A, and tes et al., 2000). These residues are situated immediately
C-terminal to (and were suggested to interfere with) thePABP1 (reviewed in Hentze, 1997; Gingras et al., 1999;
Sachs and Varani, 2000; see Figure 7). For a comparable eIF4E interacting region of eIF4G1. A database search
revealed that these residues are 63% identical to thosecomplex to exist during the pioneer round of translation,
CBP80-CBP20 would interact with eIF4G analogously in S. cerevisiae eIF4G2, but they show no obvious simi-
larity to either human eIF4G1 or human eIF4G2 (datato the way eIF4E interacts with eIF4G; similarly, PABP2
would functionally replace PABP1 (Figure 7). not shown). Therefore, there is currently no indication
for mammalian cells that eIF4G interacts directly withConsistent with recent studies of mammalian cells
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CBP80 and eIF4G, unlike the situation in S. cerevisiae,
where eIF4E and CBP80 can simultaneously be present
in eIF4G1-containing complexes independent of RNA
(Fortes et al., 2000).
There is also no evidence for mammalian cells that
eIF4G interacts with CBP20. A database search revealed
that CBP20 and eIF4E from S. cerevisiae, D. melanogas-
ter, and humans likely derived from a common ancestor.
For example, human CBP20 and human eIF4E share
26% amino acid similarity throughout their lengths (data
not shown). Mutation of Trp73 in human eIF4E or the
corresponding Trp75 in S. cerevisiae eIF4E has been
shown to abolish the interaction with eIF4G (Pyronnet
et al., 1999; Marcotrigiano et al., 1999; Ptushkina et al.,
1998). While human CBP20 can be aligned with human
and S. cerevisiae eIF4E, human CBP20 lacks a Trp resi-
due that would be required if it were to interact with
eIF4G as does eIF4E (data not shown).
With regard to the possibility that PABP2 interacts
with eIF4G in mammalian cells, PABP1 contains four
RRMs, the two N-terminal of which in human and
S. cerevisiae are critical for the interaction with eIF4G
(Imataka et al., 1998; Kessler and Sachs, 1998). Since
PABP2 contains only a single RRM (Wahle et al., 1993;
Nemeth et al., 1995), and since a single RRM either does
not interact, or in the case of RRM2 of human PABP1
Figure 6. The NMD of CBP80-Bound GPx1 mRNA Is Cytoplasmic interacts only weakly, with eIF4G (Imataka et al., 1998),
it is not likely that PABP2 interacts significantly withAs in Figure 2 except that GPx1 mRNA was analyzed in place of Gl
mRNA, and the analysis of NRS was omitted. The efficiency of eIF4G in mammalian cells.
NMD varied by no more than 5% in two independently performed Upf2 protein has been proposed to interact with eIF4A
experiments. In the RNA analysis, the righthand box represents a because it, like its S. cerevisiae counterpart, harbors
separate and more efficient transfection relative to the leftmost box.
regions similar to those of eIF4G that interact with eIF4A
(Mendell et al., 2000; Lykke-Andersen et al., 2000; Serin
CBP80 as it does in S. cerevisiae. Exemplifying another et al., 2001) and has been shown using two-hybrid analy-
apparent difference between yeast and mammals, eIF4E sis to interact directly with eIF4AI (Mendell et al., 2000).
We were not able to assay for the presence of eIF4A inwas not detected in immunopurifications containing
Figure 7. Model for the Pioneer Translation
Initiation Complex, Shown Relative to the
Steady-State Translation Initiation Complex
The pioneer translation initiation complex,
which is the substrate for NMD (as well as
the first round of translation for both non-
sense-free and nonsense-containing mRNAs),
contains CBP80-CBP20 bound to the mRNA
cap structure, PABP2 bound to the poly(A)
tail, and Upf2 and Upf3 proteins probably
bound close to, but upstream of, exon-exon
junctions. Notably, the number of Upf2 and
Upf3 molecules per cell is adequate for bind-
ing to the majority of exon-exon junctions
(L.E.M. and G.S, in press). At least for mRNAs
subject to cytoplasmic NMD, this complex
functions in association with cytoplasmic ri-
bosomes. It is uncertain if eIF4G is a multipur-
pose adaptor as it is in the steady-state trans-
lation initiation complex (Hentze, 1997; Gingras
et al., 1999; Sachs and Varani, 2000), although
it is present. Yellow and dark orange repre-
sentations of proteins with question marks
signify the possible presence of components
of the complex that binds mRNA as a
consequence of splicing in the nucleus (Le Hir et al., 2000a, 2000b) and is thought to recruit Upf3 protein. Alternatively, or additionally, Upf3
protein may interact with RNA directly, since it contains an RRM-like domain (Lykke-Andersen et al., 2000). Upf1 protein is thought to associate
after translation initiation, possibly as a consequence of translation termination (see Discussion). The presence of eIF3 has yet to be tested,
and the low specificity of available anti-eIF4A antibody precluded eIF4A detection (data not shown). The bulk of cellular translation involves
the steady-state translation initiation complex, which derives from remodeling of the pioneer translation initiation complex.
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immunopurifications using either anti-CBP80 or anti- mRNA exists that is immune to NMD. These findings
Upf3/3X antibody because available anti-eIF4A antibody indicate that the complete disappearance of nonsense-
had insufficient reactivity (data not shown). Neither were containing GPx1 mRNA 12 hr after promoter inactivation
we able to detect a complex of Upf2 protein and either must reflect not only NMD but also decay of the fraction
eIF4AI or eIF4AIII in immunopurifications of epitope- of mRNA that escaped NMD. Future studies aim to deter-
tagged versions of each protein that were transiently mine the requirements for CBP80 replacement by eIF4E.
produced in HeLa cells (Serin et al., 2001). Nevertheless,
Experimental Proceduresit is still possible that Upf2 protein functions to acceler-
ate NMD by competing with eIF4G binding proteins
Cell Culture, Plasmids, and Transfection(Mendell et al., 2000).
Monkey kidney Cos-7 and mouse NIH3T3 cells were cultured in
Interestingly, Upf1 protein was not detected in anti- MEM- (Gibco BRL) supplemented with 10% FCS. Cells were trans-
CBP80 immunopurifications. This protein, a group 1 fected with test plasmids pmCMV-Gl (Norm or 39Ter; Sun et al.,
RNA helicase known to function in NMD (Sun et al., 1998) or pmCMV-GPx1 (Norm or 46Ter, also called 46 TAA; Moriarty
et al., 1998) and reference plasmid phCMV-MUP (Belgrader and1998; Bhattacharya et al., 2000; Pal et al., 2001), has
Maquat, 1994) by using calcium phosphate (Wigler et al., 1979).been shown to coimmunoprecipitate with Upf2 and Upf3
Where indicated, cycloheximide (100 g/ml; Sigma) was added 2 hrproteins in RNase-treated HeLa cell extract (Lykke-Ander-
before harvesting. Alternatively, either p53tsSu, which expressessen et al., 2000) as well as in cells that have been tran-
an amber suppressor tRNA (Belgrader et al., 1993), or a derivative
siently transfected with Upf protein expression plasmids of p53tsSu that harbored the amber suppressor tRNA in antisense
(Serin et al., 2001). It may be that the interaction of Upf1 orientation was included in the transfection.
protein with mRNP is too transient to detect. A number
of observations support this possibility. (1) A mutated Antibodies to Human Upf2 and Upf3 Proteins
Rabbit polyclonal antisera were raised (Rockland, Inc.) against His6-Upf1 protein that functions in a dominant-negative man-
tagged human Upf2 protein (Serin et al., 2001; amino acids 441–761)ner impairs NMD in HeLa cells when wild-type Upf3 or
and His6-tagged human Upf3 protein (Serin et al., 2001; amino acidsUpf2 protein but not wild-type Upf1 protein is tethered
1–177). Each antibody was purified using protein A agarose (Sigma)
downstream of a nonsense codon, arguing that Upf1 following the protocol described in Harlow and Lane (1999).
protein acts downstream of the Upf3 and Upf2 proteins
(Lykke-Andersen et al., 2000). (2) Upf3 protein is nuclear, Cell Lysis and Immunopurifications
Upf2 protein is cytoplasmic but perinuclear, and Upf1 Immunopurification and RT-PCR were according to Chu et al. (1999),
with modification. Briefly, two days after transfection, 3.2  107 Cos-7protein is cytoplasmic (Lykke-Andersen et al., 2000; Se-
cells, or where indicated, NIH3T3 cells were washed three timesrin et al., 2001), possibly reflecting the order of assembly
with ice-cold phosphate-buffered saline (PBS). Cells were harvestedon spliced mRNA. (3) The finding that Upf3 protein inter-
and suspended in PBS. After centrifugation, cell pellets were resus-acts directly with Upf2 protein, which in turn interacts
pended in 0.5 ml of NET-2 buffer (50 mM Tris-HCl, [pH 7.4], 300 mM
directly with Upf1 protein (Serin et al., 2001), also sug- NaCl, 0.05% NP-40) containing 100 U of RNase-inhibitor (Promega).
gests that Upf1 protein may be the last Upf protein to Cells were sonicated with three 10 s bursts using a Branson Sonifier.
bind to spliced mRNA. Similarly to what has been re- After sonication, homogenates were centrifuged at 10,000  g for
10 min at 4C. The supernatants were used as the source of antigencently proposed (Lykke-Andersen et al., 2000), ribo-
in the immunopurifications. They were first cleared by incubationsomes translating mRNA during the pioneer round of
with end-over-end rotation in the presence of 100 l of proteintranslation may displace Upf2 and Upf3 proteins bound
A-agarose beads (Boehringer Mannheim) for 30 min at 4C followed
at or near exon-exon junctions located either upstream by centrifugation at 10,000  g. Cleared supernatants were then
or less than 50–55 nucleotides downstream of a transla- rotated in the presence of a specific anti-serum for 90 min at 4C,
tion termination codon. However, if translation termi- after which 0.5 mg of yeast tRNA (Sigma), 100 U of RNase-inhibitor,
nates more than 50–55 nucleotides upstream of an exon- and protein A-agarose beads was added. The incubation was con-
tinued for another 60 min at 4C. The beads were washed six timesexon junction, then Upf1 protein, which in S. cerevisiae
with NET-2 buffer, suspended in 50 l of SDS sample buffer (0.1 Mfunctions in translation termination and binds to release
Tris-HCl [pH 6.8], 4% SDS, 20% glycerol, 12% 2-mercaptoethanol),factors (Czaplinski et al., 1998; Wang et al., 2001), may
and split into two portions. In some experiments, RNase A (20 g;
interact with the downstream complex of bound Upf2 Sigma) or, as a control, BSA (20 g; New England Biolabs) was
and Upf3 proteins after translation termination and elicit added to the beads immediately prior to splitting. One portion (six-
NMD. tenths) was used as a source of protein, which was analyzed by
SDS-PAGE and Western blotting. The other portion (four-tenths)All data previous to this study indicated that nucleus-
was extracted with phenol, chloroform, and isoamyl alcohol, andassociated NMD is restricted to newly synthesized
precipitated using ethanol. Precipitates were dissolved in 50 l ofmRNA given that mRNA released into the cytoplasm is
NET-2 buffer, treated with 10 U of DNase I (Promega) for 15 min atimmune to NMD (for review, see Maquat, 1995, 2000; Li
37C, extracted, precipitated, dissolved in 30 l of water, and used
and Wilkinson, 1998; Hentze and Kulozik, 1999). How- as a source of RNA for RT-PCR (Sun et al., 1998). Notably, this
ever, our finding for GPx1 mRNA, which is subject to protocol was scaled up to include as many as eight individual immu-
cytoplasmic NMD, that the level of cytoplasmic non- nopurifications, which were pooled as a source of protein and RNA.
In cases where nuclear and cytoplasmic fractions were analyzed,sense-containing mRNA becomes undetectable 12 hr
nuclei and cytoplasm were separated from 1–2  108 transfectedafter promoter inactivation, while the level of cyto-
cells as previously described (Belgrader et al., 1994).plasmic nonsense-free mRNA was only slightly reduced,
led us to propose that cytoplasmic NMD is not limited
Western Blot Analysisto newly synthesized mRNA (Sun et al., 2000). This con-
Immunopurified protein or protein prior to immunopurification
clusion must be revised with our findings here that the (5–10 l) was electrophoresed in 8% (eIF4G, Upf1 protein or Upf2
cytoplasmic NMD of GPx1 mRNA, like nucleus-associ- protein), 10% (CBP80), 12% (eIF4E or CBP20), 15% (rpL10), or a
ated NMD of Gl mRNA, takes place in association with gradient of 4%–15% polyacrylamide (Bio-Rad) either with or without
(PABP2) 12% 2-mercaptoethanol. Protein was transferred to Hy-CBP80, and that a population of eIF4E-bound GPx1
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bond ECL nitrocellulose (Amersham), and probed with antibody Das, B., Guo, Z., Russo, P., Chartrand, P., and Sherman, F. (2000).
The role of nuclear cap binding protein Cbc1p of yeast in mRNAagainst CBP80 (Izaurralde et al., 1994), CBP20 (Izaurralde et al.,
1995), eIF4E (Morley and McKendrick, 1997), eIF4G (Morley and termination and degradation. Mol. Cell. Biol. 20, 2827–2838.
McKendrick, 1997), PABP2 (Krause et al., 1994), Upf1 protein (Pal Dostie, J., Lejbkowicz, F., and Sonenberg, N. (2000). Nuclear eukary-
et al., 2001), Upf2 protein, Upf3 protein, or ribosomal protein (rp) otic initiation factor 4E (eIF4E) colocalizes with splicing factors in
L10 (QM rabbit polyclonal IgG; Santa Cruz Biotechnology). In the speckles. J. Cell Biol. 148, 239–247.
case of cellular fractionations, nuclear fractions were deemed free Fortes, P., Inada, T., Preiss, T., Hentze, M.W., Mattaj, I.W., and
of cytoplasm by the absence of detectable reactivity with antibody Sachs, A.B. (2000). The yeast nuclear cap binding complex can
against eIF4A (Lejbkowicz et al., 1992). Reactivity to each primary interact with translation factor eIF4G and mediate translation initia-
antibody was detected using a 1:5000 dilution of horseradish peroxi- tion. Mol. Cell 6, 191–196.
dase-conjugated donkey anti-rabbit antibody (Amersham). Reactiv-
Frischmeyer, P.A., and Dietz, H.C. (1999). Nonsense-mediatedity of the secondary antibody was visualized by SuperSignal West
mRNA decay in health and disease. Hum. Mol. Genet. 8, 1893–1900.Pico or West Femto Solution (Pierce).
Gingras, A.-C., Raught, B., and Sonenberg, N. (1999). eIF4 initiation
factors: effectors of mRNA recruitment to ribosomes and regulatorsRT-PCR
of translation. Annu. Rev. Biochem. 68, 913–963.Immunopurified Gl, GPx1, or MUP transcripts (10 l) or transcripts
prior to immunopurification were analyzed by RT-PCR as described Harlow, E., and Lane, D. (1999). Using Antibodies: A Laboratory
(Sun et al., 1998). GPx1 RNA was amplified using the primers 5 Manual (Cold Spring Harbor, NY: Cold Spring Harbor Laboratory
ACCACCGTAGAACGCAGATCG 3 (sense) and 5 CTTCTCACCATT Press), pp. 74–76.
CACCTCGCACTT 3 (antisense). Gl RNA was amplified using the same Hentze, M.W. (1997). eIF4G: A multipurpose ribosome adapter? Sci-
sense primer that was used to amplify Gl RNA and 5GGGTTTAGTG ence 275, 500–501.
GTACTTGTGAGC 3 (antisense). MUP RNA was amplified using 5
Hentze, M.W., and Kulozik, A.E. (1999). A perfect message: RNACTGATGGGGCTCTATG 3 (sense) and 5 TCCTGGTGAGAAGT
surveillance and nonsense-mediated decay. Cell 96, 307–310.CTCC 3 (antisense). Half of each RT-PCR reaction was electropho-
Imataka, H., Gradi, A., and Sonenberg, N. (1998). A newly identifiedresed in 5% polyacrylamide. The simultaneous analysis of serial
N-terminal amino acid sequence of human eIF4G binds poly(A) bind-dilutions of RNA ensured that the RT-PCR was quantitative. RT-PCR
ing protein and functions in poly(A)-dependent translation. EMBOproducts were quantitated by PhosphorImaging (Molecular Dynamics).
J. 17, 7480–7489.
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